KDR and neoplasm: A series of proteins, including vascular endothelial growth factor receptor-2 (VEGFR2), integrins αvβ3, and CD105, are overexpressed on the surface of tumor vascular endothelial cells, and could be exploited for tumor vascular targeting by drug-loaded nanoparticles, which are functionalized with corresponding targeting moieties.87